I'll say this. The Actavis/Watson reps suck. Just look at all their numbers! There are also circumstances where they not only suck, but doctors flat out don't care for them, my territory is one of them. Most don't even know their names, that's pathetic. So, theoretically, could we hand over LoLo to a Watson rep and have them do contract work of just dropping it off? Absolutely. However, WC reps, and I don't care what you say, have momentum with this product and flat out better relationships, which in turn, can drive more business. This could go either way, and there are surely to be lay offs in whc, mostly on WC's side, however, it would not make business sense to take reps who have always done well and are still doing well, out of their territory and give the product to a rep who has done nothing in a territory with no relationships. We have done all the leg work, selling, and transitioning over the last two years on this product, so, again they essentially could get away with a neutral growth, but nothing more. And in a territory where docs particularly like their WC rep, it MAY hinder rx's. At the end of the day, both companies combined will now have 3 OC's, Estrace, Osteo drugs, and a couple other products Watson brought. That's a huge portfolio that in my eyes will be divided amongst both reps in any given territory. Territories where there is a 3 tier over lap, someone, most likely WC employee, will be let go. But I do not think it will be to the tune of 300 reps.
Not even close.